FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells

Journal of Immunology

Volumn 178, Issue 4, 2007, Pages 2458-2468

  Daniel, Carolin ^a   Sartory, Nico ^a   Zahn, Nadine ^a   Geisslinger, Gerd ^a   Radeke, Heinfried H ^a   Stein, Juergen M ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DEXAMETHASONE; FINGOLIMOD; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 12P70; SPHINGOSINE 1 PHOSPHATE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TRINITROBENZENESULFONIC ACID;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BAGG ALBINO MOUSE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; COLITIS; CONTROLLED STUDY; DENDRITIC CELL; DRUG MECHANISM; HISTOPATHOLOGY; LAMINA PROPRIA; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL;

EID: 33846908988     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.4.2458     Document Type: Article

References (62)

1. Chiba, K., Y. Hoshino, C. Suzuki, Y. Masubuchi, Y. Yanagawa, M. Ohtsuki, S. Sasaki, and T. Fujita. 1996. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats. Transplant. Proc. 28: 1056-1059.
2. Kiuchi, M., K. Adachi, T. Kohara, K. Teshima, Y. Masubuchi, T. Mishina, and T. Fujita. 1998. Synthesis and biological evaluation of 2,2-disubstituted 2-aminoethanols: analogues of FTY720. Bioorg. Med. Chem. Lett. 8: 101-106.
3. Kiuchi, M., K. Adachi, T. Kohara, M. Minoguchi, T. Hanano, Y. Aoki, T. Mishina, M. Arita, N. Nakao, M. Ohtsuki, et al. 2000. Synthesis and immunosuppressive activity of 2-substituted 2-aminopropane-1,3-diols and 2-aminoethanols. J. Med. Chem. 43: 2946-2961.
4. Yanagawa, Y., K. Sugahara, H. Kataoka, T. Kawaguchi, Y. Masubuchi, and K. Chiba. 1998. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. J. Immunol. 160: 5493-5499.
5. Graler, M. H., and E. J. Goetzl. 2004. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J. 18: 551-553.
6. Kharel, Y., S. Lee, A. H. Snyder, S. L. Sheasley-O'Neill, M. A. Morris, Y. Setiady, R. Zhu, M. A. Zigler, T. L. Burcin, K. Ley, et al. 2005. Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. J. Biol. Chem. 280: 36865-36872.
7. Brinkmann, V., D. Pinschewer, K. Chiba, and L. Feng. 2000. FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation. Trends Pharmacol. Sci. 21: 49-52.
8. Goetzl, E. J., and H. Rosen. 2004. Regulation of immunity by lysosphingolipids and their G protein-coupled receptors. J. Clin. Invest. 114: 1531-1537.
9. Brinkmann, V., C. Wilt, C. Kristofic, Z. Nikolova, R. P. Hof, S. Chen, R. Albert, and S. Cottens. 2001. FTY720: dissection of membrane receptor-operated, stereospecific effects on cell migration from receptor-independent antiproliferative and apoptotic effects. Transplant. Proc. 33: 3078-3080.
10. Cyster, J. G. 2005. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 23: 127-159.
11. Pinschewer, D. D., A. F. Ochsenbein, B. Odermatt, V. Brinkmann, H. Hengartner, and R. M. Zinkernagel. 2000. FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory. J. Immunol. 164: 5761-5770.
12. Rosen, H., G. Sanna, and C. Alfonso. 2003. Egress: a receptor-regulated step in lymphocyte trafficking. Immunol. Rev. 195: 160-177.
13. Budde, K., L. Schmouder, B. Nashan, R. Brunkhorst, W. Lucker, T. Mayer, L. Brookman, J. Nedelman, A. Skerjanec, T. Bohler, and H. H. Neumayer. 2003. Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients. Am. J. Transplant. 3: 846-854.
14. Chiba, K., Y. Yanagawa, Y. Masubuchi, H. Kataoka, T. Kawaguchi, M. Ohtsuki, and Y. Hoshino. 1998. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J. Immunol. 160: 5037-5044.
15. Kovarik, J. M., R. Schmouder, D. Barilla, Y. Wang, and G. Kraus. 2004. Single-dose FTY720 pharmacokinetics, food effect, and pharmacological responses in healthy subjects. Br. J. Clin. Pharmacol. 57: 586-591.
16. Matsuura, M., T. Imayoshi, and T. Okumoto. 2000. Effect of FTY720, a novel immunosuppressant, on adjuvant- and collagen-induced arthritis in rats. Int. J. Immunopharmacol. 22: 323-331.
17. Suzuki, S., S. Enosawa, T. Kakefuda, X. K. Li, M. Mitsusada, S. Takahara, and H. Amemiya. 1996. Immunosuppressive effect of a new drug, FTY720, on lymphocyte responses in vitro and cardiac allograft survival in rats. Transpl. Immunol. 4: 252-255.
18. Fiocchi, C. 1998. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115: 182-205.
19. Braegger, C. P., and T. T. MacDonald. 1994. Immune mechanisms in chronic inflammatory bowel disease. Ann. Allergy 72: 135-141.
20. Brandtzaeg, P., G. Haraldsen, and J. Rugtveit. 1997. Immunopathology of human inflammatory bowel disease. Springer Semin. Immunopathol. 18: 555-589.
21. + regulatory T cells cure murine colitis: the role of IL-10, TGF-β, and CTLA4. J. Immunol. 171: 5012-5017.
22. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192: 295-302.
23. + regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J. Immunol. 170: 394-399.
24. Maloy, K. J., and F. Powrie. 2001. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2: 816-822.
25. + regulatory T Cells. FASEB J. 18: 1043-1045.
26. + T-regulatory cells and enhances their functional activity. J. Immunol. 175: 7973-7980.
27. Muller, H., S. Hofer, N. Kaneider, H. Neuwirt, B. Mosheimer, G. Mayer, G. Konwalinka, C. Heufler, and M. Tiefenthaler. 2005. The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells. Eur. J. Immunol. 35: 533-545.
28. Radeke, H. H., H. von Wenckstern, K. Stoidtner, B. Sauer, S. Hammer, and B. Kleuser. 2005. Overlapping signaling pathways of sphingosine 1-phosphate and TGF-β in the murine Langerhans cell line XS52. J. Immunol. 174: 2778-2786.
29. Xin, C., S. Ren, B. Kleuser, S. Shabahang, W. Eberhardt, H. Radeke, M. Schafer-Korting, J. Pfeilschifter, and A. Huwiler. 2004. Sphingosine 1-phosphate cross-activates the Smad signaling cascade and mimics transforming growth factor-β-induced cell responses. J. Biol. Chem. 279: 35255-35262.
30. Xin, C., S. Ren, W. Eberhardt, J. Pfeilschifter, and A. Huwiler. 2006. The immunomodulator FTY720 and its phosphorylated derivative activate the Smad signalling cascade and upregulate connective tissue growth factor and collagen type IV expression in renal mesangial cells. Br. J. Pharmacol. 147: 164-174.
31. Idzko, M., E. Panther, S. Corinti, A. Morelli, D. Ferrari, Y. Herouy, S. Dichmann, M. Mockenhaupt, P. Gebicke-Haerter, F. Di Virgilio, et al. 2002. Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses. FASEB J. 16: 625-627.
32. Renkl, A., L. Berod, M. Mockenhaupt, M. Idzko, E. Panther, C. Termeer, P. Elsner, M. Huber, and J. Norgauer. 2004. Distinct effects of sphingosine-1-phosphate, lysophosphatidic acid and histamine in human and mouse dendritic cells. Int. J. Mol. Med. 13: 203-209.
33. Payne, S. G., C. A. Oskeritzian, R. Griffiths, P. Subramanian, S. E. Barbour, C. E. Chalfant, S. Milstien, and S. Spiegel. The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors. Blood. In press.
34. + T lymphocytes. Proc. Natl. Acad. Sci. USA 102: 11817-11822.
35. Hartmann, G., C. Bidlingmaier, B. Siegmund, S. Albrich, J. Schulze, K. Tschoep, A. Eigler, H. A. Lehr, and S. Endres. 2000. Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in mice. J. Pharmacol. Exp. Ther. 292: 22-30.
36. Wallace, J. L., and C. M. Keenan. 1990. An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. Am. J. Physiol. 258: G527-G534.
37. Asseman, C., S. Mauze, M. W. Leach, R. L. Coffman, and F. Powrie. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190: 995-1004.
38. Boirivant, M., I. J. Fuss, A. Chu, and W. Strober. 1998. Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J. Exp. Med. 188: 1929-1939.
39. Bradley, P. P., D. A. Priebat, R. D. Christensen, and G. Rothstein. 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78: 206-209.
40. van der Heijden, P. J., and W. Stok. 1987. Improved procedure for the isolation of functionally active lymphoid cells from the murine intestine. J. Immunol. Methods 103: 161-167.
41. + T cells. J. Exp. Med. 188: 1849-1857.
42. Pentcheva-Hoang, T., J. G. Egen, K. Wojnoonski, and J. P. Allison. 2004. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 21: 401-413.
43. Bandhuvula, P., Y. Y. Tam, B. Oskouian, and J. D. Saba. 2005. The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity. J. Biol. Chem. 280: 33697-33700.
44. Wang, W., M. H. Graeler, and E. J. Goetzl. 2005. Type 4 sphingosine 1-phosphate G protein-coupled receptor (S1P4) transduces S1P effects on T cell proliferation and cytokine secretion without signaling migration. FASEB J. 19: 1731-1733.
45. Mizushima, T., T. Ito, D. Kishi, Y. Kai, H. Tamagawa, R. Nezu, H. Kiyono, and H. Matsuda. 2004. Therapeutic effects of a new lymphocyte homing reagent FTY720 in interleukin-10 gene-deficient mice with colitis. Inflamm. Bowel Dis. 10: 182-192.
46. Ziegler, S. F. 2006. FOXP3: of mice and men. Annu. Rev. Immunol. 24: 209-226.
47. Coombes, J. L., N. J. Robinson, K. J. Maloy, H. H. Uhlig, and F. Powrie. 2005. Regulatory T cells and intestinal homeostasis. Immunol. Rev. 204: 184-194.
48. Powrie, F., and K. J. Maloy. 2003. Immunology: regulating the regulators. Science 299: 1030-1031.
49. + regulatory T cells. Nat. Immunol. 4: 330-336.
50. + T cells. J. Immunol. 173: 6526-6531.
51. Wan, Y. Y., and R. A. Flavell. 2005. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102: 5126-5131.
52. Fuss, I. J., M. Boirivant, B. Lacy, and W. Strober. 2002. The interrelated roles of TGF-β and IL-10 in the regulation of experimental colitis. J. Immunol. 168: 900-908.
53. Shi, Y., and J. Massague. 2003. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113: 685-700.
54. Kitani, A., I. J. Fuss, K. Nakamura, O. M. Schwartz, T. Usui, and W. Strober. 2000. Treatment of experimental (trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-β1 plasmid: TGF-β1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor β2 chain downregulation. J. Exp. Med. 192: 41-52.
55. + regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3: 135-142.
56. Nocentini, G., and C. Riccardi. 2005. GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur. J. Immunol. 35: 1016-1022.
57. Watts, T. H. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23: 23-68.
58. Ronchetti, S., O. Zollo, S. Bruscoli, M. Agostini, R. Bianchini, G. Nocentini, E. Ayroldi, and C. Riccardi. 2004. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur. J. Immunol. 34: 613-622.
59. Sanchez-Fueyo, A., M. Weber, C. Domenig, T. B. Strom, and X. X. Zheng. 2002. Tracking the immunoregulatory mechanisms active during allograft tolerance. J. Immunol. 168: 2274-2281.
60. Zheng, X. X., T. G. Markees, W. W. Hancock, Y. Li, D. L. Greiner, X. C. Li, J. P. Mordes, M. H. Sayegh, A. A. Rossini, and T. B. Strom. 1999. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment. J. Immunol. 162: 4983-4990.
61. + regulatory T cells. Int. Immunol. 16: 1643-1656.
62. + regulatory cells. J. Immunol. 176: 3321-3329.